Active substance
Desogestrel
- SFDA 3
- NHS prices 1
- Safety 9
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| CERAZETTE 75MCG TAB | 75 µg | Film-coated tablet · Oral use | 28 Blister | SAR 17.85 | NCE · Prescription | N.V. Organon | Valid |
| DESIRETT 75 mcg Film-Coated Tablets | 0.075 mg | Film-coated tablet · Oral use | 28 Blister | SAR 13.05 | Generic · Prescription | EXELTIS GERMANY GmbH | Valid |
| DESOGEST 0.075 mg tablet | 0.075 mg | Tablet · Oral use | 28 Blister | SAR 14.50 | Generic · Prescription | OMAN PHARMACEUTICAL PRODUCTS | Valid |
Indications — CHI Daman Drug Formulary
CONTRACEPTION
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Desogestrel 75microgram tablets | £1.96 | 84 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- EMA PRAC 9 Jul 2026 PRAC signal: Meningioma
Action for MAH: update of the product information: Yes - EMA PRAC 27 Nov 2025 PRAC signal: Meningioma
Action for MAH: update of the product information: No - EMA PRAC 8 May 2025 PRAC signal: Meningioma
Action for MAH: update of the product information: No - US FDA 4 Jan 2023 MIRCETTE — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions; Patient Counseling Information / Patient Information / Medication Guide - US FDA 29 Apr 2022 CYCLESSA — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions; Patient Counseling Information / Patient Information / Medication Guide - EMA PRAC 11 Jun 2020 PRAC signal: Suppressed lactation
Action for MAH: update of the product information: Yes - EMA PRAC 16 Jan 2020 PRAC signal: Suppressed lactation
Action for MAH: update of the product information: No - US FDA 15 Jun 2018 DESOGEN — safety-related labeling change
Labeling sections changed: Boxed Warning; Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions; Patient Counseling Information / Patient Information / Medication Guide - US FDA 9 Aug 2017 ORTHO-CEPT — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Drug Interactions; Patient Counseling Information / Patient Information / Medication Guide
Combinations containing Desogestrel
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.